Cardiovascular adverse events associated with BRAF versus BRAF/MEK inhibitor: Cross-sectional and longitudinal analysis using two large national registries.

Cancer Med · 2021 · PMC8209554 · PMID 33982883

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

tended toward significanceno p-value reported

None of the individual events achieved statistical significance, but HF (HR: 2.66, Gray K‐Sample p ‐value: 0.052) and new or worsening arterial hypertension (HR: 1.66, Gray K‐Sample p ‐value: 0.06) tended toward significance.

also in 121 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.